Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate efficacy and tolerability of lozenges containing
20 mg a mbroxol hydrochloride (Mucoangin?) relative to lozenges containing placebo and
lozenges containing 3 mg benzocaine in relieving pain of sore throat in patients suffering
from acute viral pharyngitis.